Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Press Release Elite Pharmaceuticals Inc Reports Financial Results For The Third Quarter Of Fiscal Year 2019 Ended December 31 2018 And Provides Conference Call Information is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates
Leverage the Nasdaq+ Scorecard to analyze stocks based on your investment priorities and our market data. Read More
Reliance, Inc. Reports First Quarter 2024 Financial Results
Net sales of $3.64 billion with tons sold up 10.3% from fourth quarter of 2023– Gross profit margin of 31.0%– EPS of $5.23, non-GAAP EPS of ... Read More
Salarius Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Fourth Quarter Financial Results Net loss ... Report on Form 10-K for the fiscal year ended December 31, 2023, as revised or supplemented by its Quarterly Reports on Form 10-Q and other documents ... Read More
LFTD Partners Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
Earnings Conference Call and Webcast Information: LFTD Partners will host an earnings conference call and webcast today, Monday, April 1, 2024 at 8:30 AM ET to discuss the foregoing financial results ... Read More
Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results
Feb. 29, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica ... today announced financial results for the fourth quarter and year ended December 31, 2023. Read More
Merrimack Pharmaceuticals, Inc. Reports Third Quarter 2023 Financial Results
Merrimack reported a net loss of $279 thousand for the third quarter ended September 30, 2023, or $0.02 per basic and diluted share on a fully diluted basis, compared to a net loss of $442 ... Read More
Resources Connection, Inc. Reports Financial Results for Third Quarter Fiscal 2024
April 03, 2024--(BUSINESS WIRE)--Resources Connection, Inc ... financial results for its fiscal third quarter ended February 24, 2024. Third Quarter Fiscal 2024 Highlights Compared to the Prior ... Read More
Salarius Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
We believe these data, if positive, will further enhance our opportunities to maximize shareholder value,” said William McVicar, Ph.D., Chairman of the Salarius Pharmaceuticals Board of Directors. Read More
Lexicon Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Provides Business Update
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results for the three months ended December 31, 2023 and provided an update on key corporate milestones. “2023 was a pivota ... Read More
Salarius Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
HOUSTON, March 22, 2024 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq ... today reported financial results for the three and 12 months ended December 31, 2023 and provided a business ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus